Author:
Liao Shijun,Zhao Wen,Yin Shiyuan,Xu Jiaming,Yang Lvying,Yang Yanhui,Yan Huan,Ou Tao,Zeng Xiaofei
Reference38 articles.
1. Analysis of status and countermeasures of cancer incidence and mortality in China;Wu;Sci. China Life Sci.,2019
2. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Kutz;JAMA Oncol.,2017
3. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?;Feng;Cancer Commun. (Lond).,2019
4. Ferroptosis-related genes in lung adenocarcinoma: prognostic signature and immune, drug resistance, mutation analysis;Ren;Front. Genet.,2021
5. A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis;Wang;Cancer Lett.,2021